Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart FailureA Randomized Controlled Trial
Top Cited Papers
Open Access
- 27 March 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 287 (12) , 1541-1547
- https://doi.org/10.1001/jama.287.12.1541
Abstract
Chronic heart failure is one of the most common and life-threatening cardiovascular conditions, affecting nearly 5 million people in the United States.1 It causes more than 200 000 deaths each year2-4 and is the leading discharge diagnosis among the Medicare population.5,6 Treatment costs for chronic heart failure, most of which are incurred by inpatients, are more than $30 billion yearly.7 Almost half of the patients with advanced disease will die within 1 year.8 Hospitalization is common in these patients and is associated with a poor prognosis.9 From 3 to 6 months after discharge, readmission rates for chronic heart failure range from 30% to 50%.10-12Keywords
This publication has 1 reference indexed in Scilit:
- Reporting bayesian analyses of clinical trialsStatistics in Medicine, 1993